You Are Here: Home » Posts tagged with "Oncology"
Research published in the New England Journal of Medicine by scientists at the Ludwig Institute for Cancer Research and Memorial Sloan-Kettering Cancer Center showed that combining targeted radiation therapy with immunotherapy (ipilimumab), fostered a...
Researchers from UCLA’s Jonsson Comprehensive Cancer Center, together with scientists from 12 other sites in the U.S. and Australia, report for the first time that a newly approved drug for metastatic melanoma nearly doubles the median survival...
Researchers at the University of Granada and the university hospital Virgen de las Nieves in Granada have developed a new radiotherapy technique that is much less toxic than that traditionally used and only targets cancerous tissue.
This new protocol...
After a decade and a half of near stagnation, four new drugs could help make advanced prostate cancer a chronic illness instead of a terminal disease, a leading Colorado prostate cancer expert says.
“It’s not just chemotherapy. The drugs have...
Breast cancer stem cells, thought to be the sole source of tumor recurrence, are known to be resistant to radiation therapy and don’t respond well to chemotherapy.
Researchers studying a rare, lethal childhood tumor of the brainstem discovered that nearly 80 percent of the tumors have mutations in genes not previously tied to cancer. Early evidence suggests the alterations play a unique role in other aggressive...
Cancer is one of the most common causes of death in humans. The conventional cancer therapies include surgery, radiotherapy, chemotherapy, and targeting therapies, which are intended to directly destroy and eliminate tumor cells. These treatments often...
Researchers at Queen’s University in Kingston, Canada have identified a possible cause for the loss of a tumor suppressor gene (known as PTEN) that can lead to the development of more aggressive forms of prostate cancer.
“This discovery gives...
Brachytherapy for high-risk prostate cancers patients has historically been considered a less effective modality, but a new study from radiation oncologists at the Kimmel Cancer Center at Jefferson suggests otherwise. A population-based analysis looking...